highly significantp < 0.001
As expected, a highly significant difference in FIGO stage distribution was observed between the non-metastatic and metastatic groups ( p < 0.001), with all non-metastatic cases classified as early-stage disease (FIGO I–II) and all metastatic cases presenting with advanced-stage disease (FIGO III–IV).